Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors

Journal of Immune Based Therapies and Vaccines

Volumn 5, Issue , 2007, Pages

  Ghanekar, Smita A ^a   Bhatia, Sonny ^a   Ruitenberg, Joyce J ^a   Dela Rosa, Corazon ^b   Disis, Mary L ^b   Maino, Vernon C ^a   Maecker, Holden T ^a   Waters, Cory A ^a  

^a BD BIOSCIENCES   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; CYCLOOXYGENASE 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 8; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CANCER PATIENT; CELL DIFFERENTIATION; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; CYTOKINE RELEASE; DENDRITIC CELL; DONOR; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION;

EID: 34249065900     PISSN: None     EISSN: 14768518     Source Type: Journal    
DOI: 10.1186/1476-8518-5-7     Document Type: Article

References (55)

1. Banchereau J Steinman RM Dendritic cells and the control of immunity Nature 1998 392 6673 245-252 10.1038/32588 9521319
2. Fecci PE Mitchell DA Archer GE Morse MA Lyerly HK Bigner DD Sampson JH The history, evolution, and clinical use of dendritic cell-based immunization strategies in the therapy of brain tumors J Neurooncol 2003 64 1-2 161-176 10.1023/A:1024943506506 12952297
3. O'Neill DW Adams S Bhardwaj N Manipulating dendritic cell biology for the active immunotherapy of cancer Blood 2004 104 8 2235-2246 10.1182/ blood-2003-12-4392 15231572
4. Palucka AK Dhodapkar MV Paczesny S Burkeholder S Wittkowski KM Steinman RM Fay J Banchereau J Single injection of CD34+ progenitor-derived dendritic cell vaccine can lead to induction of T-cell immunity in patients with stage IV melanoma J Immunother 2003 26 5 432-439 10.1097/ 00002371-200309000-00006 12973032
5. Pedersen AE Thorn M Gad M Walter MR Johnsen HE Gaarsdal E Nikolajsen K Buus S Claesson MH Svane IM Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination Scand J Immunol 2005 61 2 147-156 10.1111/j.0300-9475.2005.01531.x 15683451
6. Della Bella S Gennaro M Vaccari M Ferraris C Nicola S Riva A Clerici M Greco M Villa ML Altered maturation of peripheral blood dendritic cells in patients with breast cancer Br J Cancer 2003 89 8 1463-1472 10.1038/ sj.bjc.6601243 14562018
7. Gabrilovich DI Corak J Ciernik IF Kavanaugh D Carbone DP Decreased antigen presentation by dendritic cells in patients with breast cancer Clin Cancer Res 1997 3 3 483-490 9815709
8. Westermann J Korner IJ Kopp J Kurz S Zenke M Dorken B Pezzutto A Cryopreservation of mature monocyte-derived human dendritic cells for vaccination: Influence on phenotype and functional properties Cancer Immunol Immunother 2003 52 3 194-198 12649749
9. Szmania S Yi Q Cottler-Fox M Rosen NA Freeman J Kordsmeier BJ Moreno A Shi J Barlogie B Tricot G van Rhee F Clinical-grade myeloma Ag pre-loaded DC vaccines retain potency after cryopreservation Cytotherapy 2005 7 4 374-384 10.1080/14653240510027235 16162460
10. John J Dalgleish A Melcher A Pandha H Cryopreserved dendritic cells for intratumoral immunotherapy do not require re-culture prior to human vaccination J Immunol Methods 2005 299 1-2 37-46 10.1016/ j.jim.2004.12.014 15890354
11. Makino M Baba M A cryopreservation method of human peripheral blood mononuclear cells for efficient production of dendritic cells Scand J Immunol 1997 45 6 618-622 10.1046/j.1365-3083.1997.d01-441.x 9201301
12. Piemonti L Monti P Zerbi A Balzano G Allavena P Di Carlo V Generation and functional characterisation of dendritic cells from patients with pancreatic carcinoma with special regard to clinical applicability Cancer Immunol Immunother 2000 49 10 544-550 10.1007/s002620000149 11129325
13. Drexhage HA Mooy P Jansen A Kerrebijn J Allaerts W Tas MP Dendritic cells in tumor growth and endocrine diseases Adv Exp Med Biol 1993 329 643-650 8379440
14. Kichler-Lakomy C Budinsky AC Wolfram R Hellan M Wiltschke C Brodowicz T Viernstein H Zielinski CC Deficiences in phenotype expression and function of dentritic cells from patients with early breast cancer Eur J Med Res 2006 11 1 7-12 16504954
15. Cella M Engering A Pinet V Pieters J Lanzavecchia A Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells Nature 1997 388 6644 782-787 10.1038/42030 9285591
16. Whiteside TL Stanson J Shurin MR Ferrone S Antigen-processing machinery in human dendritic cells: Up-regulation by maturation and down-regulation by tumor cells J Immunol 2004 173 3 1526-1534 15265880
17. Geijtenbeek TB Krooshoop DJ Bleijs DA van Vliet SJ van Duijnhoven GC Grabovsky V Alon R Figdor CG van Kooyk Y DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking Nat Immunol 2000 1 4 353-357 10.1038/ 79815 11017109
18. Relloso M Puig-Kroger A Pello OM Rodriguez-Fernandez JL de la Rosa G Longo N Navarro J Munoz-Fernandez MA Sanchez-Mateos P Corbi AL DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents J Immunol 2002 168 6 2634-2643 11884427
19. de Saint-Vis B Fugier-Vivier I Massacrier C Gaillard C Vanbervliet B Ait-Yahia S Banchereau J Liu YJ Lebecque S Caux C The cytokine profile expressed by human dendritic cells is dependent on cell subtype and mode of activation J Immunol 1998 160 4 1666-1676 9469423
20. Czerniecki BJ Cohen PA Faries M Xu S Roros JG Bedrosian I Diverse functional activity of CD83+ monocyte-derived dendritic cells and the implications for cancer vaccines Crit Rev Immunol 2001 21 1-3 157-178 11642602
21. Spisek R Bretaudeau L Barbieux I Meflah K Gregoire M Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use Cancer Immunol Immunother 2001 50 8 417-427 10.1007/s002620100215 11726136
22. Trinchieri G Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes Blood 1994 84 12 4008-4027 7994020
23. Nagorsen D Marincola FM Panelli MC Cytokine and chemokine expression profiles of maturing dendritic cells using multiprotein platform arrays Cytokine 2004 25 1 31-5 10.1016/j.cyto.2003.08.012 14687583
24. Fogel-Petrovic M Long JA Knight DA Thompson PJ Upham JW Activated human dendritic cells express inducible cyclo-oxygenase and synthesize prostaglandin E2 but not prostaglandin D2 Immunol Cell Biol 2004 82 1 47-54 10.1111/j.1440-1711.2004.01213.x 14984594
25. Ruitenberg JJ Waters CA A rapid flow cytometric method for the detection of intracellular cyclooxygenases in human whole blood monocytes and a COX-2 inducible human cell line J Immunol Methods 2003 274 1-2 93-104 10.1016/S0022-1759(02)00507-0 12609536
26. Sombroek CC Stam AG Masterson AJ Lougheed SM Schakel MJ Meijer CJ Pinedo HM van den Eertwegh AJ Scheper RJ de Gruijl TD Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation J Immunol 2002 168 9 4333-4343 11970975
27. Gualde N Harizi H Prostanoids and their receptors that modulate dendritic cell-mediated immunity Immunol Cell Biol 2004 82 4 353-360 10.1111/j.0818-9641.2004.01251.x 15283844
28. Disis ML dela Rosa C Goodell V Kuan LY Chang JC Kuus-Reichel K Clay TM Kim Lyerly H Bhatia S Ghanekar SA Maino VC Maecker HT Maximizing the retention of antigen specific lymphocyte function after cryopreservation J Immunol Methods 2006 308 1-2 13-18 10.1016/j.jim.2005.09.011 16337957
29. Thurner B Roder C Dieckmann D Heuer M Kruse M Glaser A Keikavoussi P Kampgen E Bender A Schuler G Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application J Immunol Methods 1999 223 1 1-15 10.1016/ S0022-1759(98)00208-7 10037230
30. Staras SA Dollard SC Radford KW Flanders WD Pass RF Cannon MJ Seroprevalence of cytomegalovirus infection in the United States, 1988-1994 Clin Infect Dis 2006 43 9 1143-1151 10.1086/508173 17029132
31. Kern F Surel IP Faulhaber N Frommel C Schneider-Mergener J Schonemann C Reinke P Volk HD Target structures of the CD8(+)-T-cell response to human cytomegalovirus: The 72-kilodalton major immediate-early protein revisited J Virol 1999 73 10 8179-8184 112835 10482568
32. Maecker HT Dunn HS Suni MA Khatamzas E Pitcher CJ Bunde T Persaud N Trigona W Fu TM Sinclair E Bredt BM McCune JM Maino VC Kern F Picker LJ Use of overlapping peptide mixtures as antigens for cytokine flow cytometry J Immunol Methods 2001 255 1-2 27-40 10.1016/ S0022-1759(01)00416-1 11470284
33. Osugi Y Vuckovic S Hart DN Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes Blood 2002 100 8 2858-2866 10.1182/blood.V100.8.2858 12351396
34. Lau R Wang F Jeffery G Marty V Kuniyoshi J Bade E Ryback ME Weber J Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma J Immunother 2001 24 1 66-78 10.1097/ 00002371-200101000-00008 11211150
35. Schuler G Schuler-Thurner B Steinman RM The use of dendritic cells in cancer immunotherapy Curr Opin Immunol 2003 15 2 138-147 10.1016/ S0952-7915(03)00015-3 12633662
36. Figdor CG de Vries IJ Lesterhuis WJ Melief CJ Dendritic cell immunotherapy: Mapping the way Nat Med 2004 10 5 475-480 10.1038/nm1039 15122249
37. Ridgway D The first 1000 dendritic cell vaccinees Cancer Invest 2003 21 6 873-886 10.1081/CNV-120025091 14735692
38. Dhodapkar MV Steinman RM Sapp M Desai H Fossella C Krasovsky J Donahoe SM Dunbar PR Cerundolo V Nixon DF Bhardwaj N Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells J Clin Invest 1999 104 2 173-180 408478 10411546
39. Jonuleit H Giesecke-Tuettenberg A Tuting T Thurner-Schuler B Stuge TB Paragnik L Kandemir A Lee PP Schuler G Knop J Enk AH A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection Int J Cancer 2001 93 2 243-251 10.1002/ijc.1323 11410873
40. Morse MA Mosca PJ Clay TM Lyerly HK Dendritic cell maturation in active immunotherapy strategies Expert Opin Biol Ther 2002 2 1 35-43 10.1517/ 14712598.2.1.35 11772338
41. Schuler-Thurner B Schultz ES Berger TG Weinlich G Ebner S Woerl P Bender A Feuerstein B Fritsch PO Romani N Schuler G Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells J Exp Med 2002 195 10 1279-1288 10.1084/jem.20012100 12021308
42. McIlroy D Gregoire M Optimizing dendritic cell-based anticancer immunotherapy: Maturation state does have clinical impact Cancer Immunol Immunother 2003 52 10 583-591 10.1007/s00262-003-0414-7 12827310
43. Yuan A Yu CJ Shun CT Luh KT Kuo SH Lee YC Yang PC Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients Int J Cancer 2005 115 4 545-555 10.1002/ijc.20898 15704107
44. Whittaker DS Bahjat KS Moldawer LL Clare-Salzler MJ Autoregulation of human monocyte-derived dendritic cell maturation and IL-12 production by cyclooxygenase-2-mediated prostanoid production J Immunol 2000 165 8 4298-4304 11035064
45. Pockaj BA Basu GD Pathangey LB Gray RJ Hernandez JL Gendler SJ Mukherjee P Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer Ann Surg Oncol 2004 11 3 328-339 10.1245/ ASO.2004.05.027 14993030
46. Harizi H Juzan M Pitard V Moreau JF Gualde N Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions J Immunol 2002 168 5 2255-2263 11859113
47. Eisendle K Lang A Eibl B Nachbaur D Glassl H Fiegl M Thaler J Gastl G Phenotypic and functional deficiencies of leukaemic dendritic cells from patients with chronic myeloid leukaemia Br J Haematol 2003 120 1 63-73 10.1046/j.1365-2141.2003.03979.x 12492578
48. Satthaporn S Robins A Vassanasiri W El-Sheemy M Jibril JA Clark D Valerio D Eremin O Dendritic cells are dysfunctional in patients with operable breast cancer Cancer Immunol Immunother 2004 53 6 510-518 10.1007/s00262-003-0485-5 14740176
49. Gabrilovich DI Ishida T Nadaf S Ohm JE Carbone DP Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function Clin Cancer Res 1999 5 10 2963-2970 10537366
50. Ohm JE Carbone DP Immune dysfunction in cancer patients Oncology (Williston Park) 2002 16 1 Suppl 1 11-18 11829278
51. Kiertscher SM Luo J Dubinett SM Roth MD Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells J Immunol 2000 164 3 1269-1276 10640740
52. Whiteside TL Apoptosis of immune cells in the tumor microenvironment and peripheral circulation of patients with cancer: Implications for immunotherapy Vaccine 2002 20 Suppl 4 A46-51 10.1016/ S0264-410X(02)00387-0 12477428
53. Whiteside TL Rabinowich H The role of Fas/FasL in immunosuppression induced by human tumors Cancer Immunol Immunother 1998 46 4 175-184 10.1007/s002620050476 9671140
54. Huang B Zhao J Li H He KL Chen Y Mayer L Unkeless JC Xiong H Toll-like receptors on tumor cells facilitate evasion of immune surveillance Cancer Res 2005 65 12 5009-5014 10.1158/0008-5472.CAN-05-0784 15958541
55. Ishida T Oyama T Carbone DP Gabrilovich DI Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors J Immunol 1998 161 9 4842-4851 9794417